These Smart13 knock-in mice express a modified human CD4 marker from the mouse Il13 gene locus. They are suitable for use in applications where tracking Il13-expressing hematopoietic cells is desired.
Richard M. Locksley, Univ of California San Francisco-HHMI
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Reporter) | Il13 | interleukin 13 |
The Smart13 or Il13Smart allele has a bi-cistronic IRES::CD4*F43I cassette inserted between the translational stop codon and the 3' UTR of the interleukin 13 (Il13) gene. These mice express endogenous Il13 and a cell surface membrane-anchored, non-signaling human CD4 marker. Homozygous Smart13 mice are viable and fertile. Expression of the human CD4 marker is observed in Il13-expressing cells including innate type 2 helper cells (Ih2 cells) and type 2 helper T cells (Th2). These Ih2 cells are lineage-negative innate cells that arise during type 2 immunity or in response to the epithelial cytokines IL-25 and IL-33. Ih2 cells are widely distributed in mouse tissues and are particularly prevalent in mesenteric lymph nodes, spleen, and liver.
A targeting vector was designed to insert a neomycin (neo) resistance cassette, and an internal ribosome entry site (IRES), followed by truncated human CD4 cDNA, between the stop codon and the 3' untranslated region of the interleukin 13 (Il13) gene. The truncated CD4 fragment lacking intracellular signaling capacity, also contained a point mutation resulting in an I to F substitution at position 43 of the protein, rendering the human CD4 marker incapable of interacting with mouse major histocompatibility complex class II (MHCII). The construct was electroporated into 129S4/SvJae-derived PrmCre embryonic stem (ES) cells. These PrmCre (or PC3) ES cells contain the Tg(Prm-cre)70Og transgene with the protamine promoter directing cre expression to the male germline. Correctly targeted ES cells were injected into C57BL/6 blastocysts and the resulting chimeric males were bred to C57BL/6 females to generate a colony of Il13Smart mice lacking the neo cassette. These mice were backcrossed to BALB/cJ mice (Stock No. 000651) for at least 10 generations. They were then backcrossed with CBy.SJL(B6)-Ptprca/J (Stock No. 006584) to generate Smart13 Ly5.1/5.1 homozygotes. Upon arrival at The Jackson Laboratory, mice were bred to BALB/cJ inbred mice for at least one generation to establish a colony.
Expressed Gene | CD4, CD4 molecule, human |
---|---|
Site of Expression |
Allele Name | targeted mutation 2.1, Richard M Locksley |
---|---|
Allele Type | Targeted (Reporter) |
Allele Synonym(s) | Il13Smart; IL-13Smart; Il13tm2.1(CD4)Lky; Smart13 |
Gene Symbol and Name | Il13, interleukin 13 |
Gene Synonym(s) | |
Expressed Gene | CD4, CD4 molecule, human |
Strain of Origin | 129S4/SvJae-Tg(Prm-cre)70Og |
Chromosome | 11 |
Molecular Note | A targeting vector was designed to insert a neomycin (neo) resistance cassette, and an internal ribosome entry site (IRES), followed by truncated human CD4 cDNA, between the stop codon and the 3' untranslated region. The truncated CD4 fragment(424 aa vs. 458 aa in full-length protein) lacking intracellular signaling capacity (aa 419-424 as cytoplasmic tail in truncated form vs. aa 419-458 in full-length hCD4), and also contains a point mutation resulting in an I(ATC codon) to F(TTC codon) substitution at position 43 of the protein, rendering the human CD4 marker incapable of interacting with mouse major histocompatibility complex class II (MHCII) and useful as a marker of cells expressing IL13. Cre-mediated recombination removed the neo cassette. |
When maintaining a live colony, homozygous mice may be bred together.
When using the C.129S4(Cg)-Il13tm2.1Lky/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #018869 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Il13<tm2.1Lky> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.